These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12737755)

  • 1. The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.
    Petersen E
    J Travel Med; 2003 May; 10 Suppl 1():S13-5; discussion S21. PubMed ID: 12737755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries.
    Overbosch D
    J Travel Med; 2003 May; 10 Suppl 1():S16-20; discussion S21-3. PubMed ID: 12737756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
    Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
    Camus D; Djossou F; Schilthuis HJ; Høgh B; Dutoit E; Malvy D; Roskell NS; Hedgley C; De Boever EH; Miller GB;
    Clin Infect Dis; 2004 Jun; 38(12):1716-23. PubMed ID: 15227617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atovaquone/proguanil: the need for family protection.
    Kain KC
    J Travel Med; 2003 May; 10 Suppl 1():S8-12; discussion S21. PubMed ID: 12737754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atovaquone-proguanil (malarone): an effective treatment for uncomplicated Plasmodium falciparum malaria in travelers from Denmark.
    Thybo S; Gjorup I; Ronn AM; Meyrowitsch D; Bygberg IC
    J Travel Med; 2004; 11(4):220-3. PubMed ID: 15541224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atovaquone/proguanil for plasmodium falciparum malaria.
    Sehdev PS
    Pediatr Infect Dis J; 2002 Aug; 21(8):787-9. PubMed ID: 12192170
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of atovaquone and proguanil hydrochloride for the prophylaxis of Plasmodium falciparum malaria in South Africa.
    van der Berg JD; Duvenage CS; Roskell NS; Scott TR
    Clin Ther; 1999 Apr; 21(4):741-9. PubMed ID: 10363739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of malarone in therapy of malaria tropica].
    Ziegler T; Schau A; Winkler C
    Med Klin (Munich); 2002 Aug; 97(8):455-8. PubMed ID: 12229244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
    Looareesuwan S; Chulay JD; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):533-41. PubMed ID: 10348225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atovaquone and proguanil for Plasmodium falciparum malaria.
    Radloff PD; Philipps J; Nkeyi M; Hutchinson D; Kremsner PG
    Lancet; 1996 Jun; 347(9014):1511-4. PubMed ID: 8684102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.
    Høgh B; Clarke PD; Camus D; Nothdurft HD; Overbosch D; Günther M; Joubert I; Kain KC; Shaw D; Roskell NS; Chulay JD;
    Lancet; 2000 Dec; 356(9245):1888-94. PubMed ID: 11130385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.
    Lell B; Luckner D; Ndjavé M; Scott T; Kremsner PG
    Lancet; 1998 Mar; 351(9104):709-13. PubMed ID: 9504515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.
    Looareesuwan S; Wilairatana P; Chalermarut K; Rattanapong Y; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):526-32. PubMed ID: 10348224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.
    Shanks GD; Gordon DM; Klotz FW; Aleman GM; Oloo AJ; Sadie D; Scott TR
    Clin Infect Dis; 1998 Sep; 27(3):494-9. PubMed ID: 9770146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark.
    Kofoed K; Petersen E
    J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atovaquone and proguanil hydrochloride.
    Am J Health Syst Pharm; 2000 Dec; 57(23):2165-6. PubMed ID: 11127694
    [No Abstract]   [Full Text] [Related]  

  • 19. Malaria prophylaxis for aircrew: safety of atovaquone/proguanil in healthy volunteers under aircraft cabin pressure conditions.
    Simons R; Valk PJ; Krul AJ
    J Travel Med; 2005; 12(4):210-6. PubMed ID: 16086896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers.
    Lau CL; Ramsey L; Mills LC; Furuya-Kanamori L; Mills DJ
    Clin Infect Dis; 2019 Jun; 69(1):137-143. PubMed ID: 30281083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.